Digestives & Intestinal Remedies - Kenya

  • Kenya
  • In Kenya, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$25.05m.
  • It is projected that the market will experience an annual growth rate of 3.46% from 2024 to 2029 (CAGR 2024-2029).
  • When comparing the revenue on a global scale, in China leads the market with a staggering US$4,408.00m in 2024.
  • Considering the population figures, the per person revenue in Kenya for 2024 is US$0.45.
  • In Kenya, the demand for natural and herbal digestive remedies is on the rise in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Kenya is experiencing significant growth and development. Customer preferences in the Digestives & Intestinal Remedies market in Kenya are driven by a growing awareness of digestive health and the increasing prevalence of digestive disorders. Consumers in Kenya are becoming more conscious of the importance of maintaining a healthy digestive system and are actively seeking out products that can help alleviate digestive issues such as indigestion, bloating, and constipation. This has led to a rise in demand for Digestives & Intestinal Remedies products that are specifically formulated to address these concerns.Trends in the Digestives & Intestinal Remedies market in Kenya are being shaped by several factors. Firstly, there is a growing preference for natural and herbal remedies among consumers. Many Kenyan consumers are turning to traditional herbal remedies for digestive health, such as ginger, aloe vera, and peppermint. This has led to an increase in the availability of natural Digestives & Intestinal Remedies products in the market.Another trend in the market is the emergence of probiotics and prebiotics as popular options for digestive health. Probiotics are live bacteria that can help restore the natural balance of bacteria in the gut, while prebiotics are non-digestible fibers that serve as food for the beneficial bacteria in the gut. These products are gaining popularity among consumers in Kenya who are looking for long-term solutions to their digestive issues.Local special circumstances in Kenya, such as the prevalence of traditional medicine and cultural beliefs, also play a role in shaping the Digestives & Intestinal Remedies market. Traditional medicine is deeply rooted in Kenyan culture, and many consumers still rely on traditional remedies for digestive health. This has created a niche market for traditional Digestives & Intestinal Remedies products, which cater to the specific needs and preferences of these consumers.Underlying macroeconomic factors, such as the increasing disposable income and urbanization in Kenya, are also contributing to the growth of the Digestives & Intestinal Remedies market. As more Kenyans move to urban areas and experience changes in their lifestyle and diet, the demand for Digestives & Intestinal Remedies products is expected to continue to rise. Additionally, the rising disposable income allows consumers to spend more on healthcare products, including Digestives & Intestinal Remedies.In conclusion, the Digestives & Intestinal Remedies market in Kenya is witnessing growth and development driven by customer preferences for natural and herbal remedies, the emergence of probiotics and prebiotics, local special circumstances, and underlying macroeconomic factors. As consumers become more conscious of their digestive health and seek out effective solutions, the market is expected to continue to expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)